(Q39750057)

14 September 2017

1 reference

title

Indoleamines in depression and suicide (English)

1 reference

14 September 2017

0 references

van Praag HM

1

1 reference

14 September 2017

1 January 1986

1 reference

Progress in Brain Research

14 September 2017

1 reference

14 September 2017

65

1 reference

14 September 2017

59-71

1 reference

Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Amine metabolites and neuroendocrine responses related to depression and suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Biochemical post-mortem findings in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Aggression in humans correlates with cerebrospinal fluid amine metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Aggression, suicide, and serotonin: relationships to CSF amine metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Personality and background characteristics of suicidal mental patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Hostility and Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Improvement in central monoamine metabolism in adult coeliac patients starting a gluten-free diet

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Effect of 5-Hydroxytryptophan (5-HTP) on Plasma Prolactin Levels in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Predictive Value of the Probenecid Test for the Effect of L-Dopa Therapy in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Depression, intellectual impairment, and Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Altered serotonin metabolism in depressed patients with parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Characterization of serotonin binding sites on human platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Hormone response to 5-HTP

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Human brain receptor alterations in suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Decreased tryptophan availability in endogenous depression caused by disturbed plasma leucine clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Pharmacological prevention of suicidal behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Decreased imipramine binding in the brains of patients with depressive illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Intravenous L-5-hydroxytryptophan in normal subjects: an interdisciplinary precursor loading study. Part 1: Implications of reproducible mood elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Demonstration of specific high affinity binding sites for [3H] imipramine in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

CSF 5HIAA and personal and family history of suicide in affectively III patients: A negative study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Increased serotonin-2 binding sites in frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Tritiated imipramine binding sites are decreased in the frontal cortex of suicides.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Monoamine metabolites in CSF and suicidal behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Letter: L 5-Hydroxytryptophan and mood

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

1 reference

7 January 2021

Depression, suicide and the metabolism of serotonin in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

In search of the mode of action of antidepressants 5-HTP/tyrosine mixtures in depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

CSF 5-HIAA and suicide in non-depressed schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Depression vulnerability and 5-hydroxytryptophan prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Depression type and depression severity in relation to risk of violent suicide attempt

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

An empirical study on the "cathartic effect" of attempted suicide.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Hormone response to 5-HTP: a reply.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Postsynaptic serotonergic activity in depressive patients: evaluation of the neuroendocrine strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Nutrients that Modify Brain Function

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

Rapid elevation of biogenic amine metabolites in human CSF following probenecid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960642-1

7 January 2021

10.1016/S0079-6123(08)60642-1

Identifiers

DOI

0 references

Fatcat ID

release_yq5fjsxcpnbnzannhnlcqcovye

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yq5fjsxcpnbnzannhnlcqcovye

24 November 2022

mapped directly with Wikidata item

PubMed ID

3538162

1 reference

PubMed ID

3538162